71 research outputs found
Recommended from our members
Imaging Hepatocellular Carcinoma With 68Ga-Citrate PET: First Clinical Experience.
While cross-sectional imaging with computed tomography (CT) and magnetic resonance imaging is the primary method for diagnosing hepatocellular carcinoma (HCC), they provide little biological insight into this molecularly heterogeneous disease. Nuclear imaging tools that can detect molecular subsets of tumors could greatly improve diagnosis and management of HCC. To this end, we conducted a patient study to determine whether HCC can be resolved using 68Ga-citrate positron emission tomography (PET). One patient with recurrent HCC was injected with 300 MBq of 68Ga-citrate and imaged with PET/CT 249 minutes post injection. Four (28%) of 14 hepatic lesions were avid for 68Ga-citrate. One extrahepatic lesion was not PET avid. The average maximum standardized uptake value (SUVmax) for the lesions was 7.2 (range: 6.2-8.4), while the SUVmax of the normal liver parenchyma was 4.7 and blood pool was 5.7. The avid lesions were not significantly larger than the quiescent lesions, and a prior contrast CT showed uniform enhancement among the lesions, suggesting that tumor signals are due to specific binding of the radiotracer to the transferrin receptor, rather than enhanced vascularity in the tumor microenvironment. Further studies are required in a larger patient cohort to verify the molecular basis of radiotracer uptake and the clinical utility of this tool
Análisis comparativo de pacientes con lesiones estenóticas y ectásicas coronarias
A total number of 177 patients with coronary lesions were studied. Sixty nine of them presented either a combination of stenotic and ectatic lesions (n = 18) or isolated ectatic lesions (n = 51) and 108 presented only stenotic lesions. Analyzing several clinical and epidemiological parameters we observed a significant difference with respect to the higher prevalence of hypertension among the group affected by ectatic lesions. We verified as well a higher prevalence of myocardial infarction in the group of ectasia associated to the stenotic lesions. Finally, a higher global mortality was observed in the group of ectasia associated to stenotic lesions after medical or surgical treatment
On the nature of the fourth generation neutrino and its implications
We consider the neutrino sector of a Standard Model with four generations.
While the three light neutrinos can obtain their masses from a variety of
mechanisms with or without new neutral fermions, fourth-generation neutrinos
need at least one new relatively light right-handed neutrino. If lepton number
is not conserved this neutrino must have a Majorana mass term whose size
depends on the underlying mechanism for lepton number violation. Majorana
masses for the fourth generation neutrinos induce relative large two-loop
contributions to the light neutrino masses which could be even larger than the
cosmological bounds. This sets strong limits on the mass parameters and mixings
of the fourth generation neutrinos.Comment: To be published. Few typos corrected, references update
The role of healthcare providers in HPV vaccination programs - A meeting report
The Human Papillomavirus (HPV) Prevention and Control Board convened a meeting in Bucharest, Romania (May 2018), to discuss the role of healthcare providers (HCPs) in prevention programs, with a focus on HPV vaccination and cervical cancer screening. International and local experts discussed the role that HCPs can play to increase the uptake of HPV vaccine and screening. Experts recommended: 1) increasing HCP norms of getting vaccinated; 2) training providers to make effective recommendations; 3) making culturally appropriate materials available, in local languages; and 4) centralizing and coordinating education and information material, to direct both HCPs and the general public to the best material available
Advancing Key Gaps in the Knowledge of Plasmodium vivax Cryptic Infections Using Humanized Mouse Models and Organs-on-Chips
Plasmodium vivax is the most widely distributed human malaria parasite representing 36.3% of disease burden in the South-East Asia region and the most predominant species in the region of the Americas. Recent estimates indicate that 3.3 billion of people are under risk of infection with circa 7 million clinical cases reported each year. This burden is certainly underestimated as the vast majority of chronic infections are asymptomatic. For centuries, it has been widely accepted that the only source of cryptic parasites is the liver dormant stages known as hypnozoites. However, recent evidence indicates that niches outside the liver, in particular in the spleen and the bone marrow, can represent a major source of cryptic chronic erythrocytic infections. The origin of such chronic infections is highly controversial as many key knowledge gaps remain unanswered. Yet, as parasites in these niches seem to be sheltered from immune response and antimalarial drugs, research on this area should be reinforced if elimination of malaria is to be achieved. Due to ethical and technical considerations, working with the liver, bone marrow and spleen from natural infections is very difficult. Recent advances in the development of humanized mouse models and organs-on-a-chip models, offer novel technological frontiers to study human diseases, vaccine validation and drug discovery. Here, we review current data of these frontier technologies in malaria, highlighting major challenges ahead to study P. vivax cryptic niches, which perpetuate transmission and burden
Neutrino masses from new generations
We reconsider the possibility that Majorana masses for the three known
neutrinos are generated radiatively by the presence of a fourth generation and
one right-handed neutrino with Yukawa couplings and a Majorana mass term. We
find that the observed light neutrino mass hierarchy is not compatible with low
energy universality bounds in this minimal scenario, but all present data can
be accommodated with five generations and two right-handed neutrinos. Within
this framework, we explore the parameter space regions which are currently
allowed and could lead to observable effects in neutrinoless double beta decay,
conversion in nuclei and experiments. We
also discuss the detection prospects at LHC.Comment: 28 pages, 4 figures. Version to be published. Some typos corrected.
Improved figures 3 and
Effective Lagrangian approach to neutrinoless double beta decay and neutrino masses
Neutrinoless double beta () decay can in general produce
electrons of either chirality, in contrast with the minimal Standard Model (SM)
extension with only the addition of the Weinberg operator, which predicts two
left-handed electrons in the final state. We classify the lepton number
violating (LNV) effective operators with two leptons of either chirality but no
quarks, ordered according to the magnitude of their contribution to \znbb
decay. We point out that, for each of the three chirality assignments, and , there is only one LNV operator of the corresponding type
to lowest order, and these have dimensions 5, 7 and 9, respectively. Neutrino
masses are always induced by these extra operators but can be delayed to one or
two loops, depending on the number of RH leptons entering in the operator.
Then, the comparison of the decay rate and neutrino masses
should indicate the effective scenario at work, which confronted with the LHC
searches should also eventually decide on the specific model elected by nature.
We also list the SM additions generating these operators upon integration of
the heavy modes, and discuss simple realistic examples of renormalizable
theories for each case.Comment: Accepted for publication. Few misprints corrected and new references
adde
- …